Our top pick for
Building a portfolio
CTO Realty Growth, Inc is a real estate-development business based in the US. CTO Realty Growth shares (CTO) are listed on the NYSE and all prices are listed in US Dollars. CTO Realty Growth employs 17 staff and has a trailing 12-month revenue of around 0.00.
|52-week range||$25.97 - $55.88|
|50-day moving average||$53.02|
|200-day moving average||$44.34|
|Wall St. target price||$60.33|
|Dividend yield||$1.9 (3.57%)|
|Earnings per share (TTM)||$16.69|
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Valuing CTO Realty Growth stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of CTO Realty Growth's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
CTO Realty Growth's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 3x. In other words, CTO Realty Growth shares trade at around 3x recent earnings.
That's relatively low compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The low P/E ratio could mean that investors are pessimistic about the outlook for the shares or simply that they're under-valued.
CTO Realty Growth's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $29.3 million.
The EBITDA is a measure of a CTO Realty Growth's overall financial performance and is widely used to measure a its profitability.
|Revenue TTM||$56.4 million|
|Operating margin TTM||21.22%|
|Gross profit TTM||$41.2 million|
|Return on assets TTM||1.09%|
|Return on equity TTM||24.68%|
|Market capitalisation||$316.5 million|
TTM: trailing 12 months
There are currently 111,144 CTO Realty Growth shares held short by investors – that's known as CTO Realty Growth's "short interest". This figure is 6.2% up from 104,697 last month.
There are a few different ways that this level of interest in shorting CTO Realty Growth shares can be evaluated.
CTO Realty Growth's "short interest ratio" (SIR) is the quantity of CTO Realty Growth shares currently shorted divided by the average quantity of CTO Realty Growth shares traded daily (recently around 66157.142857143). CTO Realty Growth's SIR currently stands at 1.68. In other words for every 100,000 CTO Realty Growth shares traded daily on the market, roughly 1680 shares are currently held short.
However CTO Realty Growth's short interest can also be evaluated against the total number of CTO Realty Growth shares, or, against the total number of tradable CTO Realty Growth shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case CTO Realty Growth's short interest could be expressed as 0.02% of the outstanding shares (for every 100,000 CTO Realty Growth shares in existence, roughly 20 shares are currently held short) or 0.0194% of the tradable shares (for every 100,000 tradable CTO Realty Growth shares, roughly 19 shares are currently held short).
Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against CTO Realty Growth.
Find out more about how you can short CTO Realty Growth stock.
Dividend payout ratio: 14.31% of net profits
Recently CTO Realty Growth has paid out, on average, around 14.31% of net profits as dividends. That has enabled analysts to estimate a "forward annual dividend yield" of 4.98% of the current stock value. This means that over a year, based on recent payouts (which are sadly no guarantee of future payouts), CTO Realty Growth shareholders could enjoy a 4.98% return on their shares, in the form of dividend payments. In CTO Realty Growth's case, that would currently equate to about $1.9 per share.
While CTO Realty Growth's payout ratio might seem low, this can signify that CTO Realty Growth is investing more in its future growth.
CTO Realty Growth's most recent dividend payout was on 30 March 2021. The latest dividend was paid out to all shareholders who bought their shares by 18 March 2021 (the "ex-dividend date").
CTO Realty Growth's shares were split on a 1228:1000 basis on 17 November 2020. So if you had owned 1000 shares the day before before the split, the next day you'd have owned 1228 shares. This wouldn't directly have changed the overall worth of your CTO Realty Growth shares – just the quantity. However, indirectly, the new 18.6% lower share price could have impacted the market appetite for CTO Realty Growth shares which in turn could have impacted CTO Realty Growth's share price.
Over the last 12 months, CTO Realty Growth's shares have ranged in value from as little as $25.9683 up to $55.8781. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NYSE average) beta is 1, while CTO Realty Growth's is 0.5747. This would suggest that CTO Realty Growth's shares are less volatile than average (for this exchange).
CTO Realty Growth, Inc. is a Florida-based publicly traded real estate company, which owns income properties comprised of approximately 2. 4 million square feet in diversified markets in the United States and an approximately 23. 5% interest in Alpine Income Property Trust, Inc. , a publicly traded net lease real estate investment trust (NYSE: PINE). .
Everything we know about the Talaris Therapeutics IPO, plus information on how to buy in.
Everything we know about the Sagimet Biosciences IPO, plus information on how to buy in.
Everything we know about the Zenvia IPO, plus information on how to buy in.
Everything we know about the Grove IPO, plus information on how to buy in.
Everything we know about the Pasithea Therapeutics IPO, plus information on how to buy in.
Features, fees and complaints to consider before you apply for a T. Rowe Price account.
Steps to owning and managing ZTO, with 24-hour and historical pricing before you buy.
Steps to owning and managing ZOM, with 24-hour and historical pricing before you buy.
Steps to owning and managing ZI, with 24-hour and historical pricing before you buy.
Steps to owning and managing ZKIN, with 24-hour and historical pricing before you buy.
finder.com is an independent comparison platform and information service that aims to provide you with the tools you need to make better decisions. While we are independent, the offers that appear on this site are from companies from which finder.com receives compensation. We may receive compensation from our partners for placement of their products or services. We may also receive compensation if you click on certain links posted on our site. While compensation arrangements may affect the order, position or placement of product information, it doesn't influence our assessment of those products. Please don't interpret the order in which products appear on our Site as any endorsement or recommendation from us. finder.com compares a wide range of products, providers and services but we don't provide information on all available products, providers or services. Please appreciate that there may be other options available to you than the products, providers or services covered by our service.